Department of Otolaryngology, Maternal and Child Health Hospital of Hubei Province, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Department of Otolaryngology, Xiangyang Hospital of Traditional Chinese Medicine, Hubei University of Chinese Medicine, Xiangyang, China.
J Clin Lab Anal. 2022 Nov;36(11):e24681. doi: 10.1002/jcla.24681. Epub 2022 Sep 26.
Cell division cycle 42 (CDC42) participates in the pathogenesis of some T-cell-mediated inflammatory diseases via regulating CD4 T-cell differentiation and inflammation response. This study aimed to evaluate the correlation of CDC42 and T helper (Th)1/Th2 cytokines with disease risk, effusion viscosity, and hearing loss degree of otitis media with effusion (OME).
CDC42, interleukin (IL)-4, and interferon-gamma (IFN-γ) in effusion and serum of 78 OME patients were determined by enzyme-linked immunosorbent assay. Besides, the effusion (irrigating fluid) and serum samples of 30 controls (adenoid hypertrophy patients without OME) were also obtained for CDC42, IL-4, and IFN-γ determination.
Effusion CDC42 and IL-4 were elevated in OME patients compared with controls (both p < 0.001). Effusion CDC42 was positively correlated with effusion IL-4 in OME patients (p = 0.004) and controls (p = 0.012) but was not related to effusion IFN-γ (both p > 0.050). Additionally, effusion CDC42 (p = 0.025) and IL-4 (p = 0.023) were increased in OME patients with mucoid effusion compared to patients with serous effusion, while effusion IFN-γ was of no difference between those patients (p = 0.215). Meanwhile, elevated effusion CDC42 (p = 0.012) and IL-4 (p = 0.033) were linked with increased hearing loss degrees, whereas effusion IFN-γ was not related to hearing loss degrees (p = 0.057). Moreover, the findings of serum CDC42, IL-4, and IFN-γ showed similar trends as effusion ones; nonetheless, their correlation with disease features was generally weaker.
OME patients present with elevated CDC42 and IL-4 levels; the latter factors are intercorrelated and positively associate with effusion viscosity and hearing loss degree.
细胞分裂周期蛋白 42(CDC42)通过调节 CD4 T 细胞分化和炎症反应参与某些 T 细胞介导的炎症性疾病的发病机制。本研究旨在评估 CDC42 与辅助性 T(Th)1/Th2 细胞因子与分泌性中耳炎(OME)的疾病风险、渗出液黏度和听力损失程度的相关性。
采用酶联免疫吸附试验测定 78 例 OME 患者的渗出液和血清中的 CDC42、白细胞介素(IL)-4 和干扰素-γ(IFN-γ)。此外,还获得了 30 例对照(无 OME 的腺样体肥大患者)的渗出液(灌洗液)和血清样本,用于测定 CDC42、IL-4 和 IFN-γ。
与对照组相比,OME 患者的渗出液 CDC42 和 IL-4 水平升高(均 p<0.001)。OME 患者的渗出液 CDC42 与 IL-4 呈正相关(p=0.004)和对照组(p=0.012),但与渗出液 IFN-γ无关(均 p>0.050)。此外,OME 患者的黏蛋白性渗出液中,渗出液 CDC42(p=0.025)和 IL-4(p=0.023)较浆液性渗出液升高,而两组患者的渗出液 IFN-γ无差异(p=0.215)。同时,升高的渗出液 CDC42(p=0.012)和 IL-4(p=0.033)与听力损失程度增加有关,而渗出液 IFN-γ与听力损失程度无关(p=0.057)。此外,血清 CDC42、IL-4 和 IFN-γ 的检测结果与渗出液的检测结果呈相似趋势,但与疾病特征的相关性普遍较弱。
OME 患者存在 CDC42 和 IL-4 水平升高;后两者因素相互关联,并与渗出液黏度和听力损失程度呈正相关。